Trial Profile
Nexavar in Relapsed Peripheral T-cell Non-Hodgkins Lymphoma.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 05 Feb 2014
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Peripheral T-cell lymphoma
- Focus Biomarker; Therapeutic Use
- Acronyms NEXT
- 07 Jul 2011 New trial record